| Gene symbol | tk |
| GTO ID | GTC1929 |
| Trial ID | NCT03596086 |
| Disease | Brain Glioblastoma Multiforme | Astrocytoma |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Adv-HSV-tk |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy Combination With Radiotherapy and Chemotherapy for Recurrent Glioblastoma Multiforme |
| Year | 2018 |
| Country | United States |
| Company sponsor | The Methodist Hospital Research Institute |
| Other ID(s) | Pro00016414 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||
|
|||||